Updated:
AFFINITY 3 MANAGEMENT, LLC
Affinity 3 Management LLC is a single family office whose origin and principals remain undisclosed in public sources.
AFFINITY 3 MANAGEMENT, LLC
Affinity 3 Management was established as a single family office, though its founding year and the identity of the family it serves are not publicly disclosed. The firm's legal registration under the name 'Affinity 3 Management, LLC' suggests a structured approach to managing family capital, but no specific founding principals or wealth origin details have been confirmed through open sources. The firm's investment strategy encompasses direct equity positions and co-investments across a range of sectors. While the specific asset class mix is not publicly detailed, the firm's activity indicates exposure to real estate, private equity, and public market securities. Confirmed holdings include a 5% stake in Fortress Biotech, a biopharmaceutical company, as of 2024 (per SEC filings, 2024). The firm also held a position in Relmada Therapeutics as of 2023 (per SEC filings, 2023). These investments suggest a focus on the healthcare and biotechnology sectors. Affinity 3 Management operates with a lean team structure typical of small single family offices. The number of professionals is not publicly known, but the firm does not appear to maintain a separate website or active LinkedIn presence, consistent with a low-publicity posture. No additional offices beyond a single registered location have been identified. The firm has not disclosed any affiliated philanthropic foundations or operating businesses. The structural differentiator of Affinity 3 Management lies in its extreme privacy. The firm appears to function as a purely private capital vehicle, with no marketing materials, no publicly available investment thesis, and no named principals. This approach is typical of family offices that prioritize anonymity over institutional engagement, placing them in the category of 'intentional unknowns' within the family office ecosystem.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
—
Country
—
City
—
Corporate office
—
Frequently asked questions
Who runs investment decisions at Affinity 3 Management?
The individuals responsible for investment decisions at Affinity 3 Management have not been publicly identified. The firm does not maintain a website, LinkedIn profile, or public filings that list principals or investment officers. This lack of transparency is consistent with a family office that intentionally avoids public disclosure.
How does Affinity 3 Management source proprietary deal flow?
Given the firm's opaque structure, the specific process for sourcing deal flow is unknown. The firm likely relies on family connections, existing professional networks, and co-investment relationships. The known positions in Fortress Biotech and Relmada Therapeutics suggest some exposure to healthcare and biotech deals.
Is Affinity 3 Management structured as a single family office or does it operate more like a venture firm?
Available records indicate Affinity 3 Management is structured as a single family office. The firm's name and legal registration as an LLC in Delaware suggest it serves one family's capital. There is no evidence of third-party capital, fund structures, or any venture-firm operations.
What investment stages does Affinity 3 Management typically target?
The firm's known holdings include stakes in publicly traded companies like Fortress Biotech and Relmada Therapeutics, indicating an ability to invest in both publicly-listed equities and potentially private companies. The exact stage preference—whether early-stage, growth, or public markets—is not publicly specified.
Which sectors does Affinity 3 Management explicitly avoid?
The firm has not publicly disclosed any sectors it avoids. The limited public holdings point to healthcare and biotechnology, but there is no confirmed list of excluded industries.
Does Affinity 3 Management maintain philanthropic structures, and how are they separated?
There is no public information indicating that Affinity 3 Management maintains a separate philanthropic foundation or charitable arm. The firm appears to operate solely as a family investment vehicle, with no disclosed affiliated charitable entities.
What is Affinity 3 Management's known posture on co-investments alongside external GPs?
The firm's holdings are limited to direct stakes in public companies, and there is no public record of co-investments alongside external general partners. The available data suggests a preference for direct equity holdings rather than fund commitments or co-investment arrangements.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: